Search the Newsreel

Law firm investigates Phreesia directors for possible breaches of fiduciary duty

Bernstein Liebhard LLP is investigating whether Phreesia, Inc.'s directors and officers breached their fiduciary duties to shareholders. The investigation seeks to determine if the company's leadership acted in the best interests of shareholders and if legal action against them is warranted. Shareholders who purchased …

PHR|Phreesia Inc|Price:10.930|

This article provides an in-depth analysis of Phreesia Inc (PHR) stock, highlighting its market trends, key figures, and analyst ratings. The company, which offers comprehensive software solutions for healthcare organizations, shows healthy fundamentals and high growth potential. Despite average stock performance over the last …

Phreesia Inc (PHR) Income Statement

This article presents the quarterly and annual income statements for Phreesia Inc (PHR), detailing financial performance metrics such as total revenue, cost of revenue, operating expenses, and net income over various fiscal periods. It also includes key financial figures for recent quarters and fiscal …

Nephros Inc (NEPH) Institutional Confidence

Nephros Inc (NEPH) has an institutional shareholding score of 5.00, placing it 96th out of 160 in its industry. The institutional shareholding proportion has increased by 6.10% quarter-over-quarter to 50.96%. James Simons is the largest institutional shareholder, holding 0.92% of outstanding shares.

Phreesia Inc (PHR) Balance Sheet

This article provides a detailed balance sheet analysis for Phreesia Inc (PHR), presenting annual and quarterly financial data from FY2020Q1 through FY2027Q1. It breaks down current and non-current assets and liabilities, shareholders' equity, and includes key financial metrics like cash and equivalents, receivables, total …

Phreesia Inc (PHR) Cash Flow

This article provides a detailed overview of Phreesia Inc.'s (PHR) cash flow statements, including operating, investing, and financing activities. It presents quarterly and annual data with year-over-year changes for various cash flow components. The content also defines key cash flow metrics like operating cash …

Nephros Inc (NEPH) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article from TradingKey addresses the revenue breakdown for Nephros Inc (NEPH), detailing business segments, regional revenue, and profit contribution. It states that the relevant financial data for these categories have not yet been disclosed by the company. The page provides a general overview …

PHR|Phreesia Inc|Price:10.220|Chg%:+0.435

This article provides a detailed company profile for Phreesia Inc (PHR), a provider of healthcare software solutions. It covers the company's business scope, financial data, market performance, and executive information. Phreesia offers SaaS-based tools for patient access, registration, payments, and clinical assessments, aiming to …

Phreesia Inc (PHR) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Phreesia Inc (PHR), outlining its major shareholders, institutional holdings, and related ETFs. It provides a breakdown of shareholder types, institutional activity over several quarters, and a list of top shareholders with their respective holdings and changes.

Nephros Inc (NEPH) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides an overview of Nephros Inc (NEPH) dividends and stock splits. It states that no dividends have been distributed over the past five years. Key financial data like market cap and P/E ratio are also presented.

Nephros Inc. (NEPH) Retreats 3.45% as Stock Tests Key Support Zone - ATR Trailing Stop

PHR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce that Phreesia, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE: PHR) and certain officers for alleged violations of federal securities laws. The lawsuit claims that Phreesia made false and misleading statements regarding slowing demand, diminished revenue visibility, and weakened …

Nephros Inc (NEPH) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Nephros Inc (NEPH), listing major individual and institutional holders and their respective proportions. It also provides a breakdown of shareholder types, including hedge funds and individual investors, and tracks institutional shareholding changes over several quarters. Key shareholders …

NEPH|Nephros Inc|Price:3.450|Chg%:-0.190

This article provides a comprehensive stock analysis of Nephros Inc (NEPH) based on TradingKey's stock score system. It highlights the company's healthy fundamentals, high growth potential with steady revenue growth, and relatively fair valuation. The analysis also covers institutional ownership, analyst ratings, and a …

Nephrocare Health Services hosts Q1FY27 earnings call on Aug 12

Phreesia and March of Dimes Partner to Help Strengthen Physician-Patient Conversations and Improve the Health of Moms and Babies

This new collaboration reaches patients and their providers with information on widespread, preventable maternal health conditions ALL-REMOTE COMPANY/WILMINGTON, Del., July 23, 2026--(BUSINESS WIRE)--Phreesia, a leader in patient intake, outreach and activation that enables one in six patient visits across the U.S., and March of …

Preeclampsia and Postpartum Depression Resources Reach Patients Before Visits

Phreesia and March of Dimes have partnered to provide timely, evidence-based educational resources to new parents, caregivers, and healthcare providers to improve maternal and infant health outcomes. This collaboration focuses on raising awareness and providing information on preeclampsia, postpartum depression, and safe sleep practices …

Phreesia Launches AI Chatbot to Connect Patients With Healthcare Providers

Phreesia has launched an AI-powered chatbot designed to streamline patient-provider connections. The new tool aims to improve the healthcare experience by facilitating easier access and communication. This development highlights Phreesia's ongoing efforts to integrate advanced technology into its platform to enhance patient engagement.

Nephros to Present at Maxim Group’s “Health, Wellness & Longevity” Virtual Summit on July 22, 2026

Nephros, Inc. (Nasdaq: NEPH) CEO Robert Banks is scheduled to present at Maxim Group’s "Health, Wellness & Longevity" virtual summit on July 22, 2026, at 10:00 a.m. ET. The summit will focus on consumer wellness trends, scientific innovations in food and beverages, and strategies …

Should Value Investors Buy Phreesia (PHR) Stock?

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. Of these, value …

MediFind Launches AI-Powered Chatbot to Help Patients Find and Book the Right Provider

ALL-REMOTE COMPANY/WILMINGTON, Del., July 21, 2026--(BUSINESS WIRE)--MediFind, a data-powered online provider directory offered by Phreesia, is announcing the launch of Chloe, its new "Find the Right Provider" chatbot. Chloe is designed to guide patients step by step through the process of finding a provider …

Phreesia (PHR) Proxy filing Summary

Phreesia (PHR) has released its proxy filing summary, detailing the upcoming annual meeting on June 24, 2026. Shareholders will vote on electing two Class I directors (Chaim Indig and Jon Kessler), ratifying KPMG LLP as the independent auditor, and conducting a non-binding advisory vote …

Nephros to Participate in the 'Health, Wellness & Longevity” Virtual Conference Presented by Maxim Group LLC on Wednesday, July 22nd at 10:00 a.m. ET

Nephros, Inc. announced that its President and CEO, Robert Banks, will present at the "Health, Wellness & Longevity" virtual conference hosted by Maxim Group LLC on Wednesday, July 22, 2026, at 10:00 a.m. ET. The conference will delve into consumer wellness and scientific innovation, …

PHR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Phreesia, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

Bronstein, Gewirtz and Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE:PHR) and its officers. The lawsuit alleges that Phreesia made false and misleading statements about its business operations and prospects, specifically regarding slowing demand, diminished revenue stream visibility, and weakened …

Nephros added to Russell Microcap Index

Nephros, Inc., a company specializing in water purification and pathogen detection, has been added to the Russell Microcap Index. This inclusion is part of the annual reconstitution of Russell indexes, which is a significant event for institutional investors. The company's CEO expressed enthusiasm for …

Phreesia (PHR) AGM 2026 Summary

This article summarizes Phreesia's (PHR) 2026 Annual General Meeting (AGM) held on June 30, 2026. Key items included the election of two Class I directors, ratification of KPMG as the independent auditor, and a non-binding advisory vote on executive compensation for FY 2026. The …

Northland initiates Nephros stock coverage with $4 price target

Northland has initiated coverage on Nephros Inc. (NASDAQ:NEPH) with a Market Perform rating and a $4.00 price target. The analyst noted that Nephros, a water filtration company, has successfully shifted its strategy under new management, leading to increased recurring sales and revenue growth. This …

Nephros | 8-K: Current report

This article is a current report filed by Nephros, likely an 8-K form, which is used to announce major events that shareholders should know about. Without further details, the specifics of the event contained within the document are not accessible.

Phreesia Principal Accounting Officer Yvonne Hui disposes of 1,247 common shares worth $13,623.24

Phreesia's Principal Accounting Officer, Yvonne Hui, reduced her stake by disposing of 1,247 common shares worth $13,623.24. This transaction, part of larger sales on July 15-16, decreased her total holding to 21,724 common shares. The news brief is generated by AI based on information …

Form 4 Phreesia Inc For: 17 July By Investing.com

This article reports on the Form 4 filing for Phreesia Inc, specifically detailing transactions that occurred on July 17th. It provides basic information about the filing and links to further details, indicating that it is a routine financial disclosure document. The content primarily focuses …

Phreesia (NYSE: PHR) executive logs RSU tax share withholding

Phreesia, Inc. executive David Linetsky, President, Network Solutions, reported an equity activity where 69 shares of common stock were withheld by the company to satisfy tax withholding obligations related to restricted stock units. This transaction, occurring on July 15, 2026, at $10.76 per share, …

Phreesia (NYSE: PHR) officer sells 1,247 shares in 10b5-1 plan

Yvonne Hui, Phreesia's Principal Accounting Officer, sold 1,247 shares of common stock at $10.92 per share on July 16, 2026, as part of a pre-arranged Rule 10b5-1 trading plan. This transaction followed the withholding of 937 shares on July 15, 2026, to cover tax …

PHREESIA, INC. (PHR) INVESTIGATION ALERT: Bernstein Liebhard Announces Investigation of Phreesia, Inc.

Bernstein Liebhard LLP has announced an investigation into Phreesia, Inc. (NYSE: PHR) to determine if its directors and officers breached fiduciary duties. Shareholders who purchased shares before May 8, 2025, are encouraged to contact the firm to discuss their legal rights and options. Bernstein …

Insider Sell Alert: Lisa Egbuonu-davis Sells Shares of Phreesia Inc (PHR)

Lisa Egbuonu-davis, a Director at Phreesia Inc (PHR), sold 536 shares of the company on July 14, 2026, reducing her holdings to 37,780 shares. This transaction is part of a trend with 1 insider buy and 57 insider sells at Phreesia over the past …

Phreesia (NYSE: PHR) director sells 536 shares in pre-set 10b5-1 trade

Phreesia, Inc. director Lisa Egbuonu-Davis reported an open-market sale of 536 shares of common stock on July 14, 2026, at a price of $10.70 per share. This transaction was conducted under a Rule 10b5-1 trading plan adopted in December 2025. Following the sale, Lisa …

Phreesia director Lisa Egbuonu-Davis sells $5,735 in stock

Phreesia director Lisa Egbuonu-Davis sold 536 shares of Phreesia, Inc. stock for $5,735 on July 14, 2026, as part of a Rule 10b5-1 trading plan. Following the sale, she directly holds 37,780 shares. The company recently reported strong Q1 fiscal 2027 earnings, surpassing expectations, …